Organization (Details) - USD ($) $ in Millions |
9 Months Ended | ||
|---|---|---|---|
Sep. 24, 2025 |
Oct. 28, 2022 |
Nov. 30, 2025 |
|
| Organization [Line Items] | |||
| Investment purchased amount | $ 8.8 | ||
| Additional equity investment | 1.6 | ||
| SBA Debentures [Member] | |||
| Organization [Line Items] | |||
| Additional long-term capital | $ 175.0 | ||
| Maximum amount of outstanding SBA debentures | 350.0 | ||
| Regulatory capital | $ 175.0 | ||
| Investment purchased amount | $ 12.3 | ||
| Collateralized Loan Obligations [Member] | |||
| Organization [Line Items] | |||
| Issued of debt | $ 402.1 |
| X | ||||||||||
- Definition Additional long-term capital. No definition available.
|
| X | ||||||||||
- Definition Investment purchased amount. No definition available.
|
| X | ||||||||||
- Definition Maximum Amount of Outstanding SBA Debentures. No definition available.
|
| X | ||||||||||
- Definition The amount of regulatory capital. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The fair value of stock issued in noncash financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|